The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses. An intravenous bolus (2 mg/kg) followed, where appropriate, by an infusion (0.4 mg/kg) resulted in an overall conversion rate of 63% (43% in atrial fibrillation, 50% in atrial flutter, 89% in atrial tachycardias). Serious cardiotoxic side effects occurred in 15%. The study shows that such a regime is useful in a selected group of patients provided certain precautions are observed.